Standout Papers

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial... 2017 2026 2020 2023 412
  1. Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial (2017)
    Philip McGuire, Philip Robson et al. American Journal of Psychiatry

Immediate Impact

56 standout
Sub-graph 1 of 22

Citing Papers

The mediating effect of internet addiction and the moderating effect of physical activity on the relationship between alexithymia and depression
2024 Standout
Bibliometric Analysis: The Main Steps
2024 Standout
2 intermediate papers

Works of D. Vasile being referenced

Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
2017 Standout

Author Peers

Author Last Decade Papers Cites
D. Vasile 144 384 62 122 25 482
Swapnil Gupta 145 335 70 140 32 567
Elizabeth Appiah‐Kusi 191 266 147 96 21 481
Amaya Austrich-Olivares 69 319 58 144 10 560
Lisa‐Marie Greenwood 70 299 118 139 35 525
M. Tannhauser 163 141 36 164 24 536
Kat Petrilli 102 454 90 147 23 550
Suhas Ganesh 126 186 62 78 27 424
Richard Whale 144 127 51 157 32 542
Willemijn A. van Gastel 203 348 132 107 15 500
Mark Montebello 114 374 82 172 31 552

All Works

Loading papers...

Rankless by CCL
2026